Radiance Biochem Private Limited
Pharmaceutical company specializing in manufacturing, refining, and trading of drugs and chemicals.
2014 | Thane, Maharashtra (India) | Active
Radiance Biochem Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 4.00 M
- Company Age 10 Year, 6 Months
- Last Filing with ROC 31 Mar 2016
- Open Charges ₹ 2.50 Cr
About Radiance Biochem
Radiance Biochem Private Limited (RBPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 August 2014 and has a history of Ten years and six months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹2.50 Cr.
Saurabh Dube and Prafulla Dixit serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100MH2014PTC257637
- Company No.
257637
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Aug 2014
- Date of AGM
30 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Who are the key members and board of directors at Radiance Biochem?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saurabh Dube  | Director | 27-Aug-2014 | Current |
| Prafulla Dixit | Additional Director | 27-May-2015 | Current |
Financial Performance of Radiance Biochem.
Radiance Biochem Private Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Radiance Biochem?
In 2016, Radiance Biochem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹25.00 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 2.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Dec 2015 | Canara Bank | ₹2.50 Cr | Open |
How Many Employees Work at Radiance Biochem?
Unlock and access historical data on people associated with Radiance Biochem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Radiance Biochem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Radiance Biochem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
